Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2025-04-03 Director's Dealing
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
部分高级管理人员减持股份计划公告
Director's Dealing Classification · 95% confidence The document is a public announcement regarding a planned shareholding reduction by a senior management member (vice general manager) of the company. It details the number of shares to be sold, the timing, the method of sale, and compliance with relevant securities laws and regulations. It does not contain financial statements, earnings data, or management discussion of financial results. It is specifically about a director/officer's personal share transactions (share reduction). Therefore, it fits the category of Director's Dealing (DIRS). The document length is under 5,000 characters and is a detailed announcement, not a brief notice or a report publication announcement. Hence, the classification is DIRS with high confidence.
2025-04-03 Chinese
关于自愿披露取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the voluntary disclosure of obtaining a medical device registration certificate. It includes details about the product, registration number, intended use, and the potential impact on the company. There is no financial data, no mention of a report or meeting, and it is not related to financial results, governance changes, or legal proceedings. It is a regulatory announcement about a product registration, which does not fit into financial report categories. Given the nature and length of the document, it best fits under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-03-27 Chinese
关于自愿披露取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the voluntary disclosure of obtaining a medical device registration certificate by a subsidiary. It details the registration certificate number, product description, intended use, and potential impact on the company. There are no financial statements, no mention of annual or quarterly reports, no voting results, no management changes, no legal proceedings, no merger or acquisition activity, and no executive compensation details. The document is relatively short (887 characters) and serves as a regulatory announcement about a product registration, which does not fit into financial report categories. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-03-04 Chinese
关于自愿披露取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the voluntary disclosure of obtaining a medical device registration certificate by a subsidiary. It includes details about the product, registration number, intended use, and potential impact on the company. The document is short (754 characters) and does not contain financial statements, earnings data, or detailed financial analysis. It is an official announcement about a regulatory or product approval event rather than a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-02-26 Chinese
2024年度业绩快报公告
Earnings Release Classification · 95% confidence The document is titled '2024 年度业绩快报公告' which translates to '2024 Annual Performance Express Report Announcement'. It contains preliminary financial data for the full year 2024, including revenue, profit, and other key financial metrics. The data is explicitly stated as preliminary and unaudited, with a note that the final audited data will be in the company's 2024 Annual Report. The document is relatively short (1983 characters) and serves as a quick earnings update rather than a full comprehensive report. This matches the characteristics of an Earnings Release (ER), which provides initial key financial highlights for a fiscal period. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks detailed financial statements and comprehensive analysis. It is also not a Report Publication Announcement (RPA) because it contains substantive financial data, not just a notice of report availability. Therefore, the correct classification is Earnings Release (ER). FY 2024
2025-02-24 Chinese
关于实施回购股份注销暨股份变动的公告
Transaction in Own Shares Classification · 95% confidence The document is an official announcement from Shenzhen Huitai Medical Device Co., Ltd. regarding the cancellation of repurchased shares and the consequent reduction in registered capital. It details the number of shares to be cancelled, the approval process including board and shareholder meetings, and the impact on the company's share capital structure. The document also references previous announcements about share repurchases and the legal compliance of the cancellation process. The content focuses on share repurchase cancellation and capital reduction, which fits the category of a company buying back or cancelling its own shares. The document length is 2730 characters, which is relatively short but contains substantive information about the share cancellation, not merely an announcement of a report. Therefore, it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). The best fitting category is "Transaction in Own Shares (POS)" as it reports on the company's share repurchase and cancellation activities.
2025-02-24 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.